Special Offer! - Free Pharmacy Design - Limited Time Offer, Hurry Up & Register Now

My Cart
In stock

ACTILYSE 50 MG VIALS I.V 2PCS

In stock
Only 1 left
SKU
10331013752

Actilyse 50mg Vials I.V is a potent thrombolytic medication containing Alteplase, used in emergency situations to dissolve dangerous blood clots. It is critical for treating acute myocardial infarction, acute ischemic stroke, and acute massive pulmonary embolism. Administered intravenously, it rapidly restores blood flow and improves patient outcomes.

Product Overview

ACTILYSE 50 MG VIALS I.V, containing Alteplase, is a critical medication designed for the emergency treatment of severe conditions caused by blood clots. Sourced from reputable pharmaceutical channels such as Nahdi Online, and often available across e-commerce platforms like and , this product offers a potent solution for acute thrombotic events.

Actilyse is a recombinant human tissue-type plasminogen activator (rt-PA). It works by dissolving existing blood clots, thereby restoring vital blood flow to affected areas.

Benefits of Use

  • Rapidly dissolves dangerous blood clots in conditions such as acute myocardial infarction (heart attack), acute ischemic stroke, and acute massive pulmonary embolism.
  • Helps to restore blood flow to vital organs. This action can potentially limit tissue damage and improve patient outcomes.
  • Administered intravenously, ensuring quick action and systemic distribution throughout the body.

How to Use

ACTILYSE 50 MG VIALS I.V is a prescription medication that must be administered by a qualified healthcare professional in a hospital setting. Its use requires specialized medical expertise.

  1. The vial containing the powder for injection is reconstituted with sterile water for injection. This must be done strictly according to the manufacturer's instructions to ensure proper dosage.
  2. The reconstituted solution is then administered intravenously. This typically involves an initial bolus dose followed by a continuous infusion.
  3. Dosage and administration rate are carefully determined by the physician. This decision is based on the patient's condition, weight, and the specific indication (e.g., stroke, myocardial infarction, pulmonary embolism).
  4. Patients are continuously monitored for signs of bleeding or other adverse reactions. This monitoring is crucial during and after administration.
  5. Strict adherence to clinical guidelines and the product's prescribing information is essential. This ensures safe and effective use of the medication.

Caution & Warnings

  • Administering Actilyse carries a significant risk of bleeding. This includes potentially life-threatening intracranial hemorrhage.
  • The medication is not suitable for patients with a history of intracranial hemorrhage, active internal bleeding, recent surgery or trauma, severe uncontrolled hypertension, or known bleeding disorders.
  • Careful patient selection and a thorough assessment of risks versus benefits are essential. This must be conducted before administration.
  • Close monitoring for signs of bleeding throughout treatment is mandatory.
  • Concomitant use of anticoagulants or antiplatelet agents may significantly increase the risk of bleeding.
  • Actilyse should only be used under the direct supervision of medical professionals. These professionals must be experienced in thrombolytic therapy.
  • Keep out of reach of children to prevent accidental ingestion or misuse.

Ingredients

  • Active Ingredient: Alteplase 50 mg (recombinant human tissue-type plasminogen activator)
  • Excipients: L-Arginine, Phosphoric acid, Polysorbate 80. These inactive ingredients help in the formulation and stability of the product.

Product Details

  • Dosage Form: Powder for solution for injection (in vials)
  • Strength: 50 mg per vial
  • Package Size: 2 vials per pack
  • Manufacturer: Boehringer Ingelheim
  • Storage: Store in a refrigerator (2°C - 8°C) before reconstitution. Protect from light. Proper storage ensures product efficacy.
More Information
Gtin 3007245698
Recommended Sale Price 5336.1
Is Wasfaty Product No
Brand Not Defined
Ingredient Name ALTEPLASE
SFDA Reg. No 3007245698
IBC 3007245698
Drug Type Prescription
Scientific Name Alteplase
Strength 50
Strength Unit mg
Form Powder for solution for injection
Admin Route Intravenous
Size 2
Size Unit Vials
Package Types Vials
Package Size 2 Vials
Storage conditions Store in a refrigerator (2°C - 8°C) before reconstitution. Protect from light.
Refrigerator Storage Yes